Sohanya Roshan Cheng - Net Worth and Insider Trading
Sohanya Roshan Cheng Net Worth
The estimated net worth of Sohanya Roshan Cheng is at least $417,120 dollars as of 2024-04-29. Sohanya Roshan Cheng is the EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc and owns about 393,509 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $417,120. Details can be seen in Sohanya Roshan Cheng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sohanya Roshan Cheng has not made any transactions after 2024-03-01 and currently still holds the listed stock(s).
Transaction Summary of Sohanya Roshan Cheng
Sohanya Roshan Cheng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sohanya Roshan Cheng owns 1 companies in total, including Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Sohanya Roshan Cheng’s form 4 insider trades.
Insider Ownership Summary of Sohanya Roshan Cheng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-03-01 | SVP Sales & Commercial Ops |
Sohanya Roshan Cheng Latest Holdings Summary
Sohanya Roshan Cheng currently owns a total of 1 stock. Sohanya Roshan Cheng owns 393,509 shares of Karyopharm Therapeutics Inc (KPTI) as of March 1, 2024, with a value of $417,120.
Latest Holdings of Sohanya Roshan Cheng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-03-01 | 393,509 | 1.06 | 417,120 |
Holding Weightings of Sohanya Roshan Cheng
Sohanya Roshan Cheng Form 4 Trading Tracker
According to the SEC Form 4 filings, Sohanya Roshan Cheng has made a total of 5 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 26,949 shares on March 1, 2024, which brought Sohanya Roshan Cheng around $31,800.
Insider Trading History of Sohanya Roshan Cheng
- 1
Sohanya Roshan Cheng Trading Performance
Sohanya Roshan Cheng Ownership Network
Ownership Network List of Sohanya Roshan Cheng
Ownership Network Relation of Sohanya Roshan Cheng
Sohanya Roshan Cheng Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Sohanya Roshan Cheng is the SVP Sales & Commercial Ops of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , director & President and CEO Richard A. Paulson , and EVP & CFO & Treasurer Michael Mason .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Sohanya Roshan Cheng made 4 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net sale of 47,442. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 38,193 shares made by Michael Mano .
In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Sohanya Roshan Cheng Mailing Address
Above is the net worth, insider trading, and ownership report for Sohanya Roshan Cheng. You might contact Sohanya Roshan Cheng via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
